Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute

2 Views
administrator
administrator
07/14/23

Omar Nadeem, MD, explains bispecific antibodies as an exciting new immunotherapy treatment option for patients with relapsed or refractory multiple myeloma. Learn more about our Multiple Myeloma Program. https://www.dana-farber.org/mu....ltiple-myeloma-progr

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next